Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results and Provides Pipeline Review
Go back to Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results and Provides Pipeline Review| EAGLE PHARMACEUT (NASDAQ: EGRX) | Delayed: 2.14 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.14 | 52 Week High | $102.48 | |||
| Open | $2.14 | 52 Week Low | $33.02 | |||
| Day High | $2.14 | P/E | N/A | |||
| Day Low | $2.14 | EPS | $-1.02 | |||
| Volume | 1 | |||||
